+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digital Therapeutics Global Market Report 2021: COVID-19 Implications and Growth

  • PDF Icon

    Report

  • 175 Pages
  • October 2021
  • Region: Global
  • The Business Research Company
  • ID: 5458710
Digital Therapeutics Global Market Report 2021: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global digital therapeutics market.





This report focuses on digital therapeutics market which is experiencing strong growth. The report gives a guide to the digital therapeutics market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase


  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for digital therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Digital Therapeutics market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider digital therapeutics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The digital therapeutics market section of the report gives context. It compares the digital therapeutics market with other segments of the digital therapeutics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, digital therapeutics indicators comparison.

Scope


Markets Covered:


  • By Product: Software; Devices
  • By Sales Channel: Business-To-Business (B2B); Business-To-Consumers (B2C)
  • By Application: Preventive Applications; Treatment Or Care-Related Applications

Companies Mentioned:


Omada Health Inc.; WellDoc Inc.; 2Morrow Inc.; Livongo Health; Propeller Health

Countries:


Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:


Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:


Five years historic and ten years forecast.

Data:


Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data segmentations:


Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:


Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Digital Therapeutics Market

What is the estimated value of the Global Digital Therapeutics Market?

The Global Digital Therapeutics Market was estimated to be valued at $4.2 billion in 2021.

What is the growth rate of the Global Digital Therapeutics Market?

The growth rate of the Global Digital Therapeutics Market is 26.1%, with an estimated value of $10.62 billion by 2025.

What is the forecasted size of the Global Digital Therapeutics Market?

The Global Digital Therapeutics Market is estimated to be worth $10.62 billion by 2025.

Who are the key companies in the Global Digital Therapeutics Market?

Key companies in the Global Digital Therapeutics Market include Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health, Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc. and Akili Interactive Labs.

Table of Contents

1. Executive Summary2. Digital therapeutics Market Characteristics3. Digital therapeutics Market Trends and Strategies4. Impact Of COVID-19 On Digital therapeutics
5. Digital therapeutics Market Size and Growth
5.1. Global Digital therapeutics Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of the Market
5.1.2. Restraints On the Market
5.2. Global Digital therapeutics Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of the Market
5.2.2. Restraints On the Market
6. Digital therapeutics Market Segmentation
6.1. Global Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Software
  • Devices
6.2. Global Digital therapeutics Market, Segmentation by Sales Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Business-To-Business (B2B)
  • Business-To-Consumers (B2C)
6.3. Global Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Preventive Applications
  • Treatment Or Care-Related Applications

7. Digital therapeutics Market Regional and Country Analysis
7.1. Global Digital therapeutics Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Digital therapeutics Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8. Asia-Pacific Digital therapeutics Market
8.1. Asia-Pacific Digital therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
8.3. Asia-Pacific Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
9. China Digital therapeutics Market
9.1. China Digital therapeutics Market Overview
9.2. China Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
9.3. China Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
10. India Digital therapeutics Market
10.1. India Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
10.2. India Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11. Japan Digital therapeutics Market
11.1. Japan Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
11.2. Japan Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12. Australia Digital therapeutics Market
12.1. Australia Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
12.2. Australia Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13. Indonesia Digital therapeutics Market
13.1. Indonesia Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
13.2. Indonesia Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14. South Korea Digital therapeutics Market
14.1. South Korea Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
14.2. South Korea Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15. Western Europe Digital therapeutics Market
15.1. Western Europe Digital therapeutics Market Overview
15.2. Western Europe Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
15.3. Western Europe Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16. UK Digital therapeutics Market
16.1. UK Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
16.2. UK Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17. Germany Digital therapeutics Market
17.1. Germany Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
17.2. Germany Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18. France Digital therapeutics Market
18.4. France Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
18.5. France Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19. Eastern Europe Digital therapeutics Market
19.1. Eastern Europe Digital therapeutics Market Overview
19.2. Eastern Europe Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
19.3. Eastern Europe Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20. Russia Digital therapeutics Market
20.1. Russia Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
20.2. Russia Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21. North America Digital therapeutics Market
21.1. North America Digital therapeutics Market Overview
21.2. North America Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
21.3. North America Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22. USA Digital therapeutics Market
22.1. USA Digital therapeutics Market Overview
22.2. USA Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
22.3. USA Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23. South America Digital therapeutics Market
23.1. South America Digital therapeutics Market Overview
23.2. South America Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
23.3. South America Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24. Brazil Digital therapeutics Market
24.1. Brazil Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
24.2. Brazil Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25. Middle East Digital therapeutics Market
25.1. Middle East Digital therapeutics Market Overview
25.2. Middle East Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
25.3. Middle East Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26. Africa Digital therapeutics Market
26.1. Africa Digital therapeutics Market Overview
26.2. Africa Digital therapeutics Market, Segmentation by Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
26.3. Africa Digital therapeutics Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
27. Digital therapeutics Market Competitive Landscape and Company Profiles
27.1. Digital therapeutics Market Competitive Landscape
27.2. Digital therapeutics Market Company Profiles
27.2.1. Omada Health Inc.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. WellDoc Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. 2Morrow Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Livongo Health
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Propeller Health
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers and Acquisitions in the Digital therapeutics Market29. Digital therapeutics Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright and Disclaimer

Executive Summary

Major players in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health, Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Mango Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic Plc., Teladoc Health Inc, and Fitbit Health Solutions.

The global digital therapeutics market is expected to grow from $3.53 billion in 2020 to $4.20 billion in 2021 at a compound annual growth rate (CAGR) of 19%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $10.62 billion in 2025 at a CAGR of 26.1%.

The digital therapeutics market consists of sales of digital therapeutics devices and software by entities (organizations, sole traders, and partnerships) that are used in the treatment of medical disorders or diseases. Digital therapeutics (DTx) are the products that give evidence-based therapeutic treatments to patients through high-quality software applications in order to prevent, manage, or treat a medical ailment or disease. Various applications and tracking devices are integrated into digital therapies for the control and cure of medical disorders. Connected devices such as insulin pumps, blood glucose meters, and wearable gadgets communicate data to a centralized system in digital therapeutics.

The main product types of digital therapeutics are devices and software. Digital therapeutics devices provide intervention to prevent, manage or treat a disease or medical disorder. This includes devices such as sensors used to track medication usage and location data. The different sales channels include business-to-business (B2B), business-to-consumer (B2C). Digital therapeutics are used in preventive applications and treatment or care-related applications.

North America was the largest region in the digital therapeutics market in 2020. The Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Technological innovation is an emerging trend gaining popularity in the digital therapeutics market. Major companies operating in the market are focused on developing technologically advanced solutions for digital therapeutics to strengthen their position. For instance, in 2020, Boehringer Ingelheim, a Germany-based pharmaceutical company, and Click Pharmaceuticals, a US-based prescription digital therapeutics business, have agreed to collaborate on the development and commercialization of a digital medication for schizophrenia patients worth more than $500 million. The treatment named CT-155 will be a mobile app developed on click's technology platform, according to the company.

In April 2020, Novartis, a Switzerland-based pharmaceutical company acquired Ambylotech for an undisclosed amount. This acquisition is expected to help Novartis to develop Amblyotech's novel digital technology to treat amblyopia or lazy eye through digital therapeutics. Amblyotech is a US-based digital therapeutics company.

The increasing use of smartphones and tablets coupled with healthcare apps is expected to propel the growth of the digital therapeutics market in the forecast period. Smartphones and tablet-based healthcare apps have numerous advantages over the lower rate of medication errors, facilitating preventive care, and more accurate staffing. For instance, according to the Groupe Speciale Mobile Association (GSMA) report, globally 2.71 billion people owned a smartphone in 2019 and the number of smartphone users in the US reached 270 million in 2020. Therefore, the increasing use of smartphones drives the growth of the digital therapeutics market.

The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Omada Health Inc.
  • WellDoc Inc.
  • 2Morrow Inc.
  • Livongo Health
  • Propeller Health
  • Pear Therapeutics
  • Canary Health Inc.
  • Noom Health Inc.
  • Mango Health Inc.
  • Akili Interactive Labs
  • Better Therapeutics
  • Happify Health
  • Kaia Health
  • Medtronic Plc
  • Teladoc Health Inc
  • Fitbit Health Solutions

Methodology

Loading
LOADING...